One of India’s comparative advantages is its Pharmaceutical Industry. Given low production and labour costs as well as an ageing global population, increasing awareness (ongoing and heightened by COVID-19) and improving accessibility and affordability, it is expected that India’s Pharma companies will benefit. It’s not without its challenges, but with increasing R&D spending and a growing local market, they will attract greater foreign and local investment. Read our article (5-7 minutes) on the current status and our thoughts on how it could play out. We also highlight the Pharma companies we currently hold in India Avenue portfolio.